- Monday, September 19, 2022
7:30 AM – 8:45 AM CT
Paradigm Shift: A New Appreciation for Methylphenidate in Adults with ADHD
7:30 AM – 8:45 AM CT
Paradigm Shift: A New Appreciation for Methylphenidate in Adults with ADHDLocation: Room 252Innovation Theater
ADHD
7:30 AM – 8:45 AM CT
Telehealth as Part of the Treatment Plan for Adults with Schizophrenia on Long-acting Injectables
7:30 AM – 8:45 AM CT
Telehealth as Part of the Treatment Plan for Adults with Schizophrenia on Long-acting InjectablesLocation: Room 255Innovation Theater
Psychotic Disorders
Technology
9:00 AM – 10:15 AM CT
Breaking Down the Barriers to Utilizing Long-Acting Injectable Antipsychotics for Schizophrenia Management
9:00 AM – 10:15 AM CT
Breaking Down the Barriers to Utilizing Long-Acting Injectable Antipsychotics for Schizophrenia ManagementLocation: Hall E2Presenter: – University of California, San Diego
Presenter: – Monarch, Charlotte, NC
Psychotic Disorders
Jonathan M. Meyer, MD – University of California, San Diego ### 861265###Presenter###Clinical Professor of Psychiatry###University of California, San Diego###Presenter: – University of California, San Diego
### @@@ Desiree Matthews, PMHNP-BC – Monarch, Charlotte, NC ### 1609624###Presenter###Psychiatric-Mental Health Nurse Practitioner, Advanced Practice Clinical Liaison ###Monarch, Charlotte, NC###Presenter: – Monarch, Charlotte, NC
###
9:00 AM – 10:15 AM CT
Clinical Approach To Diagnosing And Treating Complex ADHD: Focus Of The Triple Co-Morbidly Of ADHD, Anxiety, And Mood Disorders
9:00 AM – 10:15 AM CT
Clinical Approach To Diagnosing And Treating Complex ADHD: Focus Of The Triple Co-Morbidly Of ADHD, Anxiety, And Mood DisordersLocation: Hall E1Presenter: – Washington University
ADHD
Psychopharmacology
Gregory Mattingly, MD – Washington University ### 1550373###Presenter###Associate Clinical Professor###Washington University###Presenter: – Washington University
###
9:00 AM – 10:15 AM CT
How to Evaluate a Stalker
9:00 AM – 10:15 AM CT
How to Evaluate a StalkerLocation: Hall E3Presenter: – Case Western Reserve University
Forensic Psychiatry
Phillip Resnick, M.D. – Case Western Reserve University ### 711737###Presenter###Professor of Psychiatry###Case Western Reserve University###Presenter: – Case Western Reserve University
###
9:00 AM – 10:15 AM CT
The Role of Psychiatrists in Contraception
9:00 AM – 10:15 AM CT
The Role of Psychiatrists in ContraceptionLocation: Room 245Presenter: – Coral Psychiatry
Women’s Mental Health
Jennifer Adaeze Okwerekwu, MD, MS – Coral Psychiatry ### 1608045###Presenter###Reproductive Psychiatrist ###Coral Psychiatry ###Presenter: – Coral Psychiatry
###
10:30 AM – 11:45 AM CT
Clinical Considerations for Patients with Excessive Daytime Sleepiness due to Obstructive Sleep Apnea: Novel Strategies for Improved Management
10:30 AM – 11:45 AM CT
Clinical Considerations for Patients with Excessive Daytime Sleepiness due to Obstructive Sleep Apnea: Novel Strategies for Improved ManagementLocation: Hall E2Presenter: – Thomas Jefferson University
Presenter: – Excel Psychiatric Associates
Sleep Disorders
Karl Doghramji, MD – Thomas Jefferson University ### 699014###Presenter###Professor of Psychiatry and Director, Sleep Disorders Center###Thomas Jefferson University###Presenter: – Thomas Jefferson University
### @@@ Craig Chepke, MD, FAPA – Excel Psychiatric Associates ### 979977###Presenter###Medical Director, Excel Psychiatric Associates; Clinical Assistant Professor of Psychiatry, SUNY Upstate Medical University; Adjunct Associate Professor of Psychiatry, Atrium Health###Excel Psychiatric Associates###Presenter: – Excel Psychiatric Associates
###
10:30 AM – 11:45 AM CT
Psychedelic-assisted Psychotherapy: How is it Different from What We Already Do?
10:30 AM – 11:45 AM CT
Psychedelic-assisted Psychotherapy: How is it Different from What We Already Do?Location: Room 245Presenter: – University of California, San Francisco, School of Nursing
Psychotherapy
SANA
Andrew D. Penn, MS, PMHNP – University of California, San Francisco, School of Nursing ### 513197###Presenter###Associate Clinical Professor###University of California, San Francisco, School of Nursing###Presenter: – University of California, San Francisco, School of Nursing
###
10:30 AM – 11:45 AM CT
Somatic and Pharmacological Treatments: Reducing Near-Term Suicide Risk
10:30 AM – 11:45 AM CT
Somatic and Pharmacological Treatments: Reducing Near-Term Suicide RiskLocation: Hall E3Presenter: – Yale School of Medicine
Suicide Prevention
Samuel Wilkinson, MD – Yale School of Medicine ### 1561543###Presenter###Assistant Professor of Psychiatry; Associate Director, Yale Depression Research Program, Psychiatry, New Haven, Connecticut###Yale School of Medicine###Presenter: – Yale School of Medicine
###
10:30 AM – 11:45 AM CT
State of Schizophrenia
10:30 AM – 11:45 AM CT
State of SchizophreniaLocation: Hall E1Presenter: – (1) The Zucker Hillside Hospital; (2) Donald and Barbara Zucker School of Medicine at Hofstra/Northwell; (3) The Feinstein Institutes for Medical Research; (4) Charité - Universitätsmedizin Berlin
Psychotic Disorders
Christoph U. Correll, MD – (1) The Zucker Hillside Hospital; (2) Donald and Barbara Zucker School of Medicine at Hofstra/Northwell; (3) The Feinstein Institutes for Medical Research; (4) Charité - Universitätsmedizin Berlin ### 711740###Presenter###Medical Director; Professor###(1) The Zucker Hillside Hospital; (2) Donald and Barbara Zucker School of Medicine at Hofstra/Northwell; (3) The Feinstein Institutes for Medical Research; (4) Charité - Universitätsmedizin Berlin###Presenter: – (1) The Zucker Hillside Hospital; (2) Donald and Barbara Zucker School of Medicine at Hofstra/Northwell; (3) The Feinstein Institutes for Medical Research; (4) Charité - Universitätsmedizin Berlin
###
11:45 AM – 3:15 PM CT
Exhibit Hall
11:45 AM – 3:15 PM CT
Exhibit Hall
Location: Hall D
12:00 PM – 1:15 PM CT
Health Disparities: How Prescription Digital Therapeutics are closing gaps in care
12:00 PM – 1:15 PM CT
Health Disparities: How Prescription Digital Therapeutics are closing gaps in careLocation: Room 353Innovation Theater
Technology
12:00 PM – 1:15 PM CT
How to Introduce a Long-acting Injectable With a Longer Dosing Interval for Adult Patients With Schizophrenia Into Your Practice
12:00 PM – 1:15 PM CT
How to Introduce a Long-acting Injectable With a Longer Dosing Interval for Adult Patients With Schizophrenia Into Your PracticeLocation: Room 356Innovation Theater
Psychotic Disorders
12:00 PM – 1:15 PM CT
Making a Difference for Patients With Tardive Dyskinesia (TD) Proactively Recognizing and Treating an Overlooked Disorder
12:00 PM – 1:15 PM CT
Making a Difference for Patients With Tardive Dyskinesia (TD) Proactively Recognizing and Treating an Overlooked DisorderLocation: Room 252Innovation Theater
Psychotic Disorders
12:00 PM – 1:15 PM CT
The Efficacy and Safety Profile of an Adjunctive Therapy for Adult Patients with Major Depressive Disorder (MDD)
12:00 PM – 1:15 PM CT
The Efficacy and Safety Profile of an Adjunctive Therapy for Adult Patients with Major Depressive Disorder (MDD) Location: Room 255Innovation Theater
Depressive Disorders
1:30 PM – 3:00 PM CT
Poster Presentations in Exhibit Hall
1:30 PM – 3:00 PM CT
Poster Presentations in Exhibit Hall
Location: Hall D
1:45 PM – 3:15 PM CT
Long Acting Injectable (LAI) and Motivational Interviewing Workshop
1:45 PM – 3:15 PM CT
Long Acting Injectable (LAI) and Motivational Interviewing Workshop
Location: Hall D
2:00 PM – 3:00 PM CT
S.C.O.P.E.™ : Schizophrenia Clinical Outcome Scenarios and Patient-Provider Engagement - An Interactive Digital Platform to Educate on Schizophrenia Care
2:00 PM – 3:00 PM CT
S.C.O.P.E.™ : Schizophrenia Clinical Outcome Scenarios and Patient-Provider Engagement - An Interactive Digital Platform to Educate on Schizophrenia CareLocation: Innovation Theater in the Exhibit HallInnovation Theater
Psychotic Disorders
3:30 PM – 4:45 PM CT
Novel CGRP Monoclonal Antibodies and CGRP Receptor Antagonists: A Recipe for Success in Migraine Prevention and Treatment
3:30 PM – 4:45 PM CT
Novel CGRP Monoclonal Antibodies and CGRP Receptor Antagonists: A Recipe for Success in Migraine Prevention and TreatmentLocation: Hall E2Presenter: – Excel Psychiatric Associates
Presenter:
Psychopharmacology
Craig Chepke, MD, FAPA – Excel Psychiatric Associates ### 979977###Presenter###Medical Director, Excel Psychiatric Associates; Clinical Assistant Professor of Psychiatry, SUNY Upstate Medical University; Adjunct Associate Professor of Psychiatry, Atrium Health###Excel Psychiatric Associates###Presenter: – Excel Psychiatric Associates
### @@@ Megan Donnelly, DO ### 1762281###Presenter###Lead Neurologist and Head of Craniofacial Pain Program, Novant Health; Adjunct Professor of Medicine, UNC School of Medicine; Assistant Professor of Neurology, Campbell School of Osteopathic Medicine; Teaching Faculty for Family Medicine Residency, Novant Health######Presenter:
###
3:30 PM – 4:45 PM CT
Solving Clinical Challenges: Treatment Resistant Depression
3:30 PM – 4:45 PM CT
Solving Clinical Challenges: Treatment Resistant DepressionLocation: Hall E1Depressive Disorders
Psychopharmacology
Michael E. Thase, MD ### 513213###Presenter###Professor of Psychiatry######Presenter:
###
3:30 PM – 4:45 PM CT
The Future of Psychedelic Therapy: Training a New Generation of Clinicians
3:30 PM – 4:45 PM CT
The Future of Psychedelic Therapy: Training a New Generation of CliniciansLocation: Room 245Presenter: – NYU Langone Center for Psychedelic Medicine
Presenter: – Johns Hopkins University School of Medicine
Psychotherapy
SANA
Kelley C. O'Donnell, MD, PhD – NYU Langone Center for Psychedelic Medicine ### 1603235###Presenter###Assistant Professor of Psychiatry###NYU Langone Center for Psychedelic Medicine###Presenter: – NYU Langone Center for Psychedelic Medicine
### @@@ Natalie Gukasyan, MD – Johns Hopkins University School of Medicine ### 1603239###Presenter###Assistant Professor of Psychiatry###Johns Hopkins University School of Medicine###Presenter: – Johns Hopkins University School of Medicine
###
3:30 PM – 4:45 PM CT
Treating Agitation: Can We Avoid Injections? Should We?
3:30 PM – 4:45 PM CT
Treating Agitation: Can We Avoid Injections? Should We?Location: Hall E3Presenter: – New York Medical College
Psychopharmacology
Leslie L. Citrome, MD, MPH – New York Medical College ### 858164###Presenter###Clinical Professor of Psychiatry and Behavioral Sciences###New York Medical College###Presenter: – New York Medical College
###
5:00 PM – 6:15 PM CT
Neuroplasticity and Its Role in MDD: New Solutions with Digital Therapeutics
5:00 PM – 6:15 PM CT
Neuroplasticity and Its Role in MDD: New Solutions with Digital TherapeuticsLocation: Hall E2Presenter: – UT Southwestern Medical Center
Presenter: – Stanford University School of Medicine, Stanford, California
Depressive Disorders
Madhukar H. Trivedi, MD – UT Southwestern Medical Center ### 1332753###Presenter###Professor of Psychiatry; PI, Big South/West Node of the NIDA Funded Clinical Trails Network###UT Southwestern Medical Center###Presenter: – UT Southwestern Medical Center
### @@@ Steven R. Chan, MD, MBA – Stanford University School of Medicine, Stanford, California ### 608155###Presenter###Clinical Assistant Professor (Affiliated)###Stanford University School of Medicine, Stanford, California###Presenter: – Stanford University School of Medicine, Stanford, California
###
5:00 PM – 6:15 PM CT
Not Getting Better!- Diagnostic Conundrums and Treatment Considerations in Mood Disorders
5:00 PM – 6:15 PM CT
Not Getting Better!- Diagnostic Conundrums and Treatment Considerations in Mood DisordersLocation: Hall E3Presenter: – Washington University
Psychopharmacology
Gregory Mattingly, MD – Washington University ### 1550373###Presenter###Associate Clinical Professor###Washington University###Presenter: – Washington University
###
5:00 PM – 6:15 PM CT
Practice-friendly evaluation and treatment of pediatric mood disorders
5:00 PM – 6:15 PM CT
Practice-friendly evaluation and treatment of pediatric mood disordersLocation: Hall E1Presenter: – Stanford University
Child and Adolescent Psychiatry
Manpreet K. Singh, MD MS – Stanford University ### 1083894###Presenter###Associate Professor of Psychiatry and Behavioral Sciences###Stanford University###Presenter: – Stanford University
###
5:00 PM – 6:15 PM CT
The Many Faces of Ketamine: Merging Biological Psychiatry and Psychedelic Medicine
5:00 PM – 6:15 PM CT
The Many Faces of Ketamine: Merging Biological Psychiatry and Psychedelic MedicineLocation: Room 245Presenter: – NYU Langone Center for Psychedelic Medicine
Kelley C. O'Donnell, MD, PhD – NYU Langone Center for Psychedelic Medicine ### 1603235###Presenter###Assistant Professor of Psychiatry###NYU Langone Center for Psychedelic Medicine###Presenter: – NYU Langone Center for Psychedelic Medicine
###
6:30 PM – 7:45 PM CT
Agitation in Alzheimer’s Dementia: Progress in an Age-Old Problem
6:30 PM – 7:45 PM CT
Agitation in Alzheimer’s Dementia: Progress in an Age-Old ProblemLocation: Hall E2Presenter: – Duke University and UNC Chapel Hill Medical Centers
Presenter:
Dementia and Cognitive Disorders
Richard H. Weisler, MD – Duke University and UNC Chapel Hill Medical Centers ### 527010###Presenter###Adjunct Professor of Psychiatry###Duke University and UNC Chapel Hill Medical Centers###Presenter: – Duke University and UNC Chapel Hill Medical Centers
### @@@ Gustavo Alva, MD, DFAPA ### 861251###Presenter###Medical Director, ATP Clinical Research, Assistant Professor, Department of Psychiatry and Neuroscience, University of California, Riverside; Private Practice Psychiatrist, Pacific Neuropsychiatric Specialists, Costa Mesa, California######Presenter:
###
6:30 PM – 7:45 PM CT
Incorporating the Peer Perspective in Research
6:30 PM – 7:45 PM CT
Incorporating the Peer Perspective in ResearchLocation: Room 245Presenter:
Presenter:
Presenter:
Bipolar Disorders
Depressive Disorders
Andrew Smith, MSW, MPH ### 1518357###Presenter###Community Engagement Manager, Depression and Bipolar Support Alliance, Chicago, Illinois######Presenter:
### @@@ Christy Klein, PhD ### 1753046###Presenter#########Presenter:
### @@@ Dan Nowery ### 1762506###Presenter#########Presenter:
###
6:30 PM – 7:45 PM CT
Management of OCD and Co-occurring Substance Addiction.
6:30 PM – 7:45 PM CT
Management of OCD and Co-occurring Substance Addiction.Location: Hall E3Presenter: – University of Chicago
Obsessive-Compulsive and Related Disorders
Substance Use Disorder
Jon E. Grant, MD – University of Chicago ### 513188###Presenter###Professor###University of Chicago###Presenter: – University of Chicago
###
6:30 PM – 7:45 PM CT
Symptom Management Or Symptom Elimination? What Should Be Goal Of Treatment Of Depression In Real World Clinical Practice
6:30 PM – 7:45 PM CT
Symptom Management Or Symptom Elimination? What Should Be Goal Of Treatment Of Depression In Real World Clinical PracticeLocation: Hall E1Presenter: – Brown University
Assessment and Adherence
Psychopharmacology
Mark Zimmerman, MD – Brown University ### 513193###Presenter###Professor of Psychiatry and Human Behavior###Brown University###Presenter: – Brown University
###
